Cosmos Health's (COSM) Cana Laboratories signed a three-year contract manufacturing agreement with Verisfield for 3.9 million units of VASCLOR GEST progesterone pessaries.
The deal adds a new customer and expands Cana's women's-health manufacturing portfolio. Cosmos said Wednesday in a statement.
Financial terms weren't disclosed.
Price: $0.23, Change: $+0.01, Percent Change: +2.87%